// App-Quantinova.ai

FRI0378 : INTERLEUKIN 6 AND VASCULAR DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS

Researchers

Presenter

  • J. J. Alegre-Sancho

Principal Investigators

  • M. Robustillo-Villarino

  • J. M. Zaragoza-Garcia

  • E. Vicens-Bernabeu

  • E. Rodilla-Sala

  • M. T. Tuzon-Segarra

  • F. Gil-Latorre

  • V. Cubero-Tarin

  • C. M. Feced-Olmos

  • I. De la Morena Barrio

  • D. Ybanez-Garcia

  • E. Valls-Pascual

  • A. Martinez-Ferrer

  • J. E. Oller-Rodriguez

Medical Centers

  • Ophthalmology, Hospital Universitario Dr Peset, Valencia, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Interstitial lung disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Autoimmune sclerosing cholangitis

  • Hypertension

  • Myositis

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • C reactive protein

  • High sensitivity C-reactive protein

  • Human albumin

  • Interleukin 6

Drug/Treatment

  • Interleukin

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved